US2004121390A1PendingUtilityA1

Method of preparing a standard diagnostic gene transcript pattern

Assignee: DIAGENIC ASPriority: Apr 30, 1997Filed: Dec 5, 2003Published: Jun 24, 2004
Est. expiryApr 30, 2017(expired)· nominal 20-yr term from priority
C12Q 1/6883C12Q 1/6809C12Q 1/6816
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for preparing a gene transcript pattern probe kit characteristic of a disease or condition or a stage thereof in a prokaryotic or eukaryotic organism using mRNA which is differentially expressed in the disease or condition or stage as probes, methods of diagnosis using the method and kits for performing the same are disclosed.

Claims

exact text as granted — not AI-modified
1 . A method of preparing a gene transcript pattern probe kit for diagnosing or identifying a disease or condition or stage thereof in a prokaryotic or eukaryotic organism comprising at least the steps of: 
 a) isolating mRNA from the tissue, cells or body fluid of a normal prokaryotic or eukaryotic organism (normal sample);    b) isolating mRNA from the corresponding tissue, cells or body fluid of an organism of step a) having the disease or condition of interest or a stage thereof (diseased sample);    c) separating the mRNA of steps a) and b), which may optionally be reverse transcribed to cDNA, by a non-sequence based separation technique;    d) selecting two or more mRNA or cDNA species which are present at different levels in the normal and diseased samples;    e) isolating the mRNA or cDNA species identified in step d);    f) optionally reverse transcribing the mRNA of step d) or e) to cDNA, unless this has previously been performed in step c); and    g) immobilizing the mRNA or cDNA probes of step e) or f) on one or more solid supports.    
     
     
         2 . A method as claimed in  claim 1  wherein the mRNA of steps a) and b) is reverse transcribed to cDNA.  
     
     
         3 . A method as claimed in  claim 1  or  2  wherein said cDNA is amplified.  
     
     
         4 . A method as claimed in  claim 2  or  3  wherein said cDNA produced from the mRNA of steps a) and b) incorporates a label.  
     
     
         5 . A method as claimed in any one of  claims 1  to  4  wherein between 50 and 100 mRNA or cDNA probes are isolated.  
     
     
         6 . A method as claimed in any one of  claims 1  to  5  wherein said separation technique is gel electrophoresis.  
     
     
         7 . A gene transcript pattern probe kit for diagnosing or identifying or preparing a standard diagnostic gene transcript pattern of a disease or condition or stage thereof in a eukaryotic or prokaryotic organism comprising at least the following: 
 a) one or more solid supports carrying two or more probe species as defined in any one of  claims 1  to  5  corresponding to transcripts which reflect gene expression of one or more selected genes characteristic of the condition or disease or stage thereof in the organism under investigation.    
     
     
         8 . A gene transcript pattern probe kit as claimed in  claim 7  prepared according to any one of  claims 1  to  6 .  
     
     
         9 . A kit as claimed in  claim 7  or  8  additionally comprising mRNA or cDNA from normal and/or diseased samples, for comparative purposes.  
     
     
         10 . Use of a kit as defined in any one of  claims 7  to  9  for the preparation of a standard diagnostic gene transcript pattern.  
     
     
         11 . A method of preparing a standard diagnostic gene transcript pattern characteristic of a disease or condition or stage thereof in a prokaryotic or eukaryotic organism comprising at least the steps of: 
 a) isolating mRNA from the tissue, cells or body fluid of said organism having the disease or condition or stage thereof, which may optionally be reverse transcribed to cDNA,    b) hybridizing the mRNA or cDNA of step a) to the mRNA or cDNA probes on a kit as defined in any one of  claims 7  to  9  specific for said disease or condition or stage thereof in an organism corresponding to the organism under investigation; and    c) assessing the amount of mRNA or cDNA hybridizing to each of said probes on said solid support(s) to produce a characteristic pattern reflecting gene expression in the sample with the disease, condition or stage thereof of one or more selected genes corresponding to the probes.    
     
     
         12 . A method as claimed in  claim 11  wherein said mRNA of step b) is reverse transcribed to cDNA and optionally incorporates a label.  
     
     
         13 . A method as claimed in  claim 12  wherein said cDNA is amplified.  
     
     
         14 . Use of a kit as defined in any one of  claims 7  to  9  and/or use of a standard diagnostic gene transcript pattern prepared according to any one of  claims 11  to  13  for the identification or diagnosis of said disease or condition or stage thereof in said organism.  
     
     
         15 . A method of diagnosing or identifying a disease or condition or stage thereof in a prokaryotic or eukaryotic organism, comprising the steps of: 
 a) isolating mRNA from the tissue, cells or body fluid of said organism, which may optionally be reverse transcribed to cDNA;    b) hybridizing the mRNA or cDNA of step a) to a kit as defined in any one of  claims 7  to  9  specific for said disease, or condition or stage thereof in an organism corresponding to the organism under investigation;    c) assessing the amount of mRNA or cDNA hybridizing to each of said probes on said solid supports to produce a characteristic pattern reflecting gene expression of one or more selected genes corresponding to the probes;    d) comparing said pattern to a standard diagnostic pattern prepared according to any one of  claims 11  to  13  using a sample from an organism corresponding to the organism under investigation having said disease or condition or stage thereof under investigation to determine the degree of correlation indicative of the presence of said disease or condition or a stage thereof in the organism under investigation.    
     
     
         16 . A method or kit as claimed in any one of  claims 1  to  15  wherein said organism is human.  
     
     
         17 . A method or kit as claimed in any one of  claims 1  to  16  wherein said solid support is a filter.

Join the waitlist — get patent alerts

Track US2004121390A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.